Bio Green Med Solution, Inc. (BGMS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
"Bio Green Med Solution, Inc. is currently navigating a precarious transition from speculative biopharmaceutical research to industrial fire protection services, a pivot that has yet to demonstrate a path to sustainable profitability. While the consolidation of Fitters Sdn. Bhd. has generated $778,000 in 2026Q1 revenue, the company remains burdened by a massive $454.6 million accumulated deficit and persistent negative operating margins. Investors should remain cautious as the firm's dual-industry strategy continues to consume cash reserves, necessitating ongoing reliance on external capital to offset structural operational inefficiencies."
the company's persistent negative free cash flow and a staggering $454.6 million accumulated deficit suggest that the current business model lacks the operational scale required to generate long-term shareholder value.
Bio Green Med Solution, Inc. (BGMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Bio Green Med Solution, Inc. (BGMS) EPS & revenue vs analyst estimates — last 3 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.04 | $778,000 |
| Q2 2026 | Mar 30, 2026 | $2.21vs $72.00+96.9% | $666,000vs $25,000+2564.0% |
| Q4 2025 | Nov 13, 2025 | $1.31vs $72.00+98.2% | $81,000vs $25,000+224.0% |
Key metrics vs top competitors for Bio Green Med Solution, Inc. (BGMS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.61 | $1.33M | -0.09 | 1637.21% | -401.34% | -128.45% | 4.57% | |
| $1.38 | $82.93M | -3.45 | -14.36% | -11.91% | -19.51% | — | |
| $69.91 | $4.07B | 28.30 | -3.93% | 3.27% | — | — | |
| $62.93 | $1.8B | 16.01 | -13.8% | 45.58% | 6.41% | — | |
| $29.39 | $449.13M | 33.02 | 13.74% | 6.54% | 17.76% | — | |
| $0.79 | $3.77M | -0.01 | -29.45% | -237.25% | -500.33% | — |
Bio Green Med Solution, Inc. (BGMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BGMS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Bio Green Med Solution, Inc. (BGMS) stock FAQ — growth, dividends, profitability & financials explained
Bio Green Med Solution, Inc. (BGMS) reported $1.5M in revenue for fiscal year 2025. This represents a 328% increase from $0.4M in 2005.
Bio Green Med Solution, Inc. (BGMS) grew revenue by 1637.2% over the past year. This is strong growth.
Bio Green Med Solution, Inc. (BGMS) reported a net loss of $3.1M for fiscal year 2025.
Yes, Bio Green Med Solution, Inc. (BGMS) pays a dividend with a yield of 4.57%. This makes it attractive for income-focused investors.
Bio Green Med Solution, Inc. (BGMS) has a return on equity (ROE) of -128.4%. Negative ROE indicates the company is unprofitable.
Bio Green Med Solution, Inc. (BGMS) had negative free cash flow of $1.8M in fiscal year 2025, likely due to heavy capital investments.